Old Web
English
Sign In
Acemap
>
Paper
>
Docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer: a real-life analysis
Docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer: a real-life analysis
2021
Igor Tsaur
Isabel Heidegger
Jasmin Bektic
Mona Kafka
R.C.N. Van Den Bergh
Jarmo C. B. Hunting
Anita Thomas
Maximilian P. Brandt
Thomas Höfner
E. Debedde
Constance Thibault
P. Ermacora
F. Zattoni
Silvia Foti
A. Kretschmer
Severin Rodler
Guillaume Ploussard
G. von Amsberg
Derya Tilki
Cristian Surcel
Barak Rosenzweig
Moran Gadot
G. Gandaglia
Robert Dotzauer
Keywords:
Abiraterone acetate
Oncology
Hormone sensitive prostate cancer
Internal medicine
Medicine
Docetaxel
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]